EUROLAB
usp-1086-impurities-in-drug-substances
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

Comprehensive Guide to USP <1086>: Impurities in Drug Substances Laboratory Testing Service Provided by Eurolab

USP <1086> is a comprehensive standard that outlines the requirements for testing impurities in drug substances. The standard is published by the United States Pharmacopeia (USP), an independent, non-profit organization that sets standards for the quality of pharmaceutical ingredients and products.

Relevant Standards and Regulations

The following international and national standards apply to USP <1086>:

  • ISO 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories
  • ASTM E1614-08 Standard Practice for Interlaboratory Cross Validation of Quantitative Measurement Methods
  • EN ISO/IEC 17065:2012 Conformity assessment -- Requirements for bodies certifying products, processes and services
  • TSE (Turkish Standards Institution) TS EN ISO/IEC 17025:2006 General requirements for the competence of testing and calibration laboratories
  • International and National Standards

    The following international and national standards govern USP <1086>:

  • International Standardization Organization (ISO): ISO 9001, ISO 14001
  • American Society for Testing and Materials (ASTM): ASTM E1614-08, ASTM E2650-07
  • European Committee for Standardization (CEN): EN ISO/IEC 17065:2012
  • Turkish Standards Institution (TSE): TS EN ISO/IEC 17025:2006
  • Standard Development Organizations and Their Role

    Standard development organizations play a crucial role in establishing standards that govern laboratory testing. The USP, ISO, ASTM, CEN, and TSE are some of the prominent standard development organizations responsible for developing standards related to USP <1086>.

    Evolution and Updates of Standards

    Standards evolve over time as new technologies and methodologies emerge. Standard development organizations regularly review and update existing standards to reflect changing requirements and advances in technology.

    Standard Numbers and Scope

    The following are some specific standard numbers and their scope:

  • ISO 17025:2005 - General Requirements for the Competence of Testing and Calibration Laboratories
  • ASTM E1614-08 - Standard Practice for Interlaboratory Cross Validation of Quantitative Measurement Methods
  • EN ISO/IEC 17065:2012 - Conformity assessment -- Requirements for bodies certifying products, processes and services
  • Standard Compliance Requirements

    Industry-specific standards compliance requirements include:

  • Pharmaceutical industry: USP <1086>, ICH Q3A (R2), ICH Q7
  • Food industry: FDA 21 CFR Part 110, ISO 22000:2005
  • Cosmetic industry: EU Cosmetics Regulation (1223/2009), ISO 22716:2004
  • Standard-Related Costs and Benefits

    The cost of implementing and maintaining compliance with standards can be significant. However, the benefits of standardization include improved quality, increased efficiency, and enhanced customer confidence.

    ---

    USP <1086> is a critical standard for testing impurities in drug substances. The standard outlines specific requirements for testing, including:

  • Testing methods: HPLC, GC-FID, GC-MS
  • Detection limits: 0.1, 0.01
  • Analytical procedures: extraction, purification, separation
  • Business and Technical Reasons for Conducting USP <1086> Testing

    The business and technical reasons for conducting USP <1086> testing include:

  • Ensuring product safety and efficacy
  • Maintaining regulatory compliance
  • Protecting brand reputation and customer trust
  • Mitigating risks associated with impurities
  • Consequences of Not Performing USP <1086> Testing

    Failure to conduct USP <1086> testing can result in:

  • Product recalls or withdrawals
  • Loss of market share and revenue
  • Damage to brand reputation and customer trust
  • Increased regulatory scrutiny and penalties
  • Industries and Sectors Requiring USP <1086> Testing

    The following industries and sectors require USP <1086> testing:

  • Pharmaceutical industry: API, excipients, finished products
  • Biotechnology industry: biologics, biosimilars, cell-based therapies
  • Food industry: food additives, flavorings, coloring agents
  • Risk Factors and Safety Implications

    The risk factors associated with impurities in drug substances include:

  • Toxicity: acute or chronic effects on humans or animals
  • Carcinogenicity: potential to cause cancer
  • Mutagenicity: potential to cause genetic mutations
  • Quality Assurance and Quality Control Aspects

    USP <1086> testing is an essential aspect of quality assurance and quality control. The standard ensures that laboratories follow rigorous protocols for testing, including:

  • Calibration and validation procedures
  • Measurement and analysis methods
  • Data management and reporting
  • ---

    Analytical Procedures

    The following analytical procedures are outlined in USP <1086>:

  • Extraction: liquid-liquid, solid-phase microextraction
  • Purification: SPE, HPLC, GC-FID
  • Separation: HPLC, GC-FID, GC-MS
  • Detection Limits and Limit of Quantitation (LOQ)

    The standard outlines specific detection limits for impurities in drug substances:

  • 0.1 for APIs and excipients
  • 0.01 for finished products
  • Analytical Method Validation

    Laboratories must validate their analytical methods according to the guidelines outlined in USP <1086>:

  • Specificity: ability to detect impurities without interference from other compounds
  • Sensitivity: ability to detect impurities at specified detection limits
  • Linearity: relationship between concentration and response
  • ---

    Data Management and Reporting

    The standard outlines specific requirements for data management and reporting:

  • Data accuracy and precision
  • Calibration and validation records
  • Laboratory notebook or electronic record keeping
  • Equipment Calibration and Maintenance

    Laboratories must ensure that their equipment is calibrated and maintained according to the manufacturers instructions:

  • HPLC, GC-FID, GC-MS instruments
  • SPE and extraction equipment
  • Weighing and volumetric equipment
  • Continuing Education and Training

    Laboratory personnel must participate in continuing education and training programs to stay up-to-date with the latest developments and methodologies.

    ---

    Regulatory Compliance

    USP <1086> testing is essential for regulatory compliance:

  • FDA, ICH, EU regulatory requirements
  • API, excipient, finished product regulations
  • Good Manufacturing Practice (GMP) compliance
  • Certification and Accreditation

    Laboratories must be certified or accredited by a recognized accrediting body to demonstrate their competence in USP <1086> testing.

    ---

    Conclusion

    USP <1086> is a critical standard for testing impurities in drug substances. The standard outlines specific requirements for testing, including analytical procedures, detection limits, and data management and reporting. Laboratories must ensure that they are compliant with the standard to maintain regulatory compliance and protect their brand reputation and customer trust.

    ---

    Eurolabs Capabilities

    As a leading laboratory testing services provider, Eurolab is equipped to handle USP <1086> testing requirements:

  • Experienced staff with expertise in analytical chemistry
  • State-of-the-art equipment for HPLC, GC-FID, GC-MS analysis
  • Accreditation and certification by recognized accrediting bodies
  • Conclusion

    Eurolab is committed to providing high-quality laboratory testing services that meet or exceed industry standards. Our team of experts will work closely with you to ensure that your USP <1086> testing requirements are met efficiently and effectively.

    ---

    Please note that this is a sample guide, and actual content may vary depending on the specific needs and requirements of the client.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers